TABLE 1:
Comparing patients that met ATA guidelines with those that did not: Patient Characteristics.
| Variable | ATA Prepped (n=102) | Not ATA Prepped (n=95) | P Value |
|---|---|---|---|
| Age (years) | 41.6±1.4 | 37.5±1.7 | 0.07 |
| BMI | 28.9±6.2 | 27.9±6.7 | 0.31 |
| Female Gender, % | 77.0 | 87.4 | 0.07 |
| Opthalmopathy, % | 54.9 | 46.8 | 0.26 |
| Thyroid Nodules, % | 36.6 | 36.8 | 0.98 |
| Current Smoker, % | 47.1 | 31.0 | 0.02 |
| Previous RAI, % | 9.0 | 3.3 | 0.10 |
| Thyrotoxic Crisis, % | 3.9 | 2.1 | 0.46 |
| Pregnant, % | 0.0 | 2.1 | 0.14 |
| Preoperative Methimazole, % | 91.8 | 78.0 | 0.01 |
| Months on Methimazole Preop | 9.7±1.4 | 7.9±1.5 | 0.39 |
| MMI Side Effect, % | 6.9 | 6.3 | 0.88 |
| Days on Beta-Blocker | 203.4±446.5 | 127.6±334.0 | 0.19 |
| Preoperative Lugol’s/SSKI% | 100.0 | 61.1 | 0.01 |
| Euthyroid, % | 100.0 | 46.3 | 0.01 |
| TSH Preop | 1.0±3.1 | 0.8±2.8 | 0.55 |
| T4 Preop | 1.0±0.3 | 4.4±24.0 | 0.01 |
| T3 Preop | 4.4±10.8 | 8.3±16.2 | 0.01 |
Data presented as mean± SD